Investigating oral microbiome dynamics in chronic kidney disease and post-transplantation in continuous culture

被引:0
|
作者
Campbell, Paul M. [1 ]
Willmott, Thomas [1 ]
Summers, Angela [2 ]
Knight, Christopher G. [3 ]
Humphreys, Gavin J. [1 ]
Konkel, Joanne E. [4 ]
Augustine, Titus [2 ]
Mcbain, Andrew J. [1 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Sch Hlth Sci, Manchester, England
[2] Manchester Acad Hlth Sci Ctr, Manchester Univ Hosp NHS Fdn Trust, Dept Renal & Pancreat Transplantat, Manchester, England
[3] Univ Manchester, Fac Sci & Engn, Sch Nat Sci, Manchester, England
[4] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Manchester, England
来源
MICROBIOLOGY SPECTRUM | 2024年 / 12卷 / 11期
基金
英国医学研究理事会;
关键词
urea; oral microbiome; kidney transplantation; chronic kidney disease; ANTIMICROBIAL SUSCEPTIBILITY; DENTAL BIOFILMS; PH; BACTERIA; STREPTOCOCCI; ENZYMES; HEALTH;
D O I
10.1128/spectrum.00598-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The oral microbiome is influenced by environmental factors in chronic kidney disease and following kidney transplantation affecting microbial composition, which may have implications for health and recovery. A major driver of oral microbiome perturbation is the accumulation of urea in saliva. We have modelled increased salivary urea concentrations associated with CKD and subsequent reductions that may occur post-transplantation. Oral microbiota were established in constant-depth film fermenters by inoculation with saliva. Duplicate validation runs were maintained with artificial saliva with baseline urea concentrations (0.205 mg/mL) for 21 days. Triplicate treatment runs were then done with baseline urea for 10 days (healthy phase) before urea was increased for 10 days to reflect CKD concentrations (0.92 mg/mL) (CKD phase). This was followed by reversion to baseline urea concentrations (post-transplant phase). Biofilms in primary validation runs reached dynamic stability within 5 days according to viable counting. DNA sequence data indicated minimal taxonomic variation over time and between low and high urea treatments despite background noise indicating changes in bacteria belonging to the family Gemellaceae and the genera TG5 and Leptotrichia. Significant differences in alpha and beta diversity occurred between low and high urea states but not following reversion to a low urea environment. Increased abundance of the TG5 was detected in late model phases, despite apparent count stability, and independent of changes in urea concentrations.IMPORTANCEThis study investigates dynamic changes in the oral microbiome associated with changes in salivary urea concentration, an important factor in chronic kidney disease (CKD). The in vitro system modeled increased urea concentrations and subsequent reductions post-transplantation. The study provides insight into the oral microbial shifts during different simulated clinical phases. Understanding these dynamics is crucial for advancing our comprehension of CKD-associated oral microbiome variations and their potential impact on patient well-being and recovery. This study investigates dynamic changes in the oral microbiome associated with changes in salivary urea concentration, an important factor in chronic kidney disease (CKD). The in vitro system modeled increased urea concentrations and subsequent reductions post-transplantation. The study provides insight into the oral microbial shifts during different simulated clinical phases. Understanding these dynamics is crucial for advancing our comprehension of CKD-associated oral microbiome variations and their potential impact on patient well-being and recovery.
引用
收藏
页数:16
相关论文
共 50 条
  • [11] Post-transplantation metabolic bone disease
    Ittel, TH
    Wirtz, DC
    Schmitt, H
    Sieberth, HG
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1997, 26 (05) : 192 - 200
  • [12] Post-transplantation lymphoproliferative disease - Introduction
    Klein, G
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1998, 20 (3-4): : 319 - 323
  • [13] Role of the native kidney in experimental post-transplantation hypertension
    Sander, S
    Ehrig, B
    Rettig, R
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1996, 431 (06): : 971 - 976
  • [14] Epithelioid granulomas in post-transplantation chronic graft-vs.-host disease
    Tsunemi, Y
    Ihn, H
    Saeki, H
    Tamaki, K
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (04) : 898 - 899
  • [15] EVALUATION OF ANTI-HLA IN KIDNEY POST-TRANSPLANTATION
    Ramalhete, Luis
    Sancho, Maria do Rosario
    Silva, Maria Isabel
    Ascencao Matos, M.
    Trindade, Helder
    TISSUE ANTIGENS, 2015, 85 (05): : 430 - 430
  • [16] IMPORTANCE OF RENIN IN POST-TRANSPLANTATION (SINGLE KIDNEY) HYPERTENSION
    WHELTON, PK
    RUSSELL, RP
    HARRINGTON, DP
    WHITE, RI
    WALKER, WG
    KIDNEY INTERNATIONAL, 1976, 10 (06) : 612 - 612
  • [17] Chronic kidney disease post-liver transplantation
    O'Riordan, A
    Wong, V
    McCormick, PA
    Hegarty, JE
    Watson, AW
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V367 - V367
  • [18] Chronic kidney disease post-liver transplantation
    O'Riordan, Aisling
    Wong, Vincent
    McCormick, P. Aiden
    Hegarty, John E.
    Watson, Alan J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (09) : 2630 - 2636
  • [19] Microbiome in Chronic Kidney Disease
    Tourountzis, Theodoros
    Lioulios, Georgios
    Fylaktou, Asimina
    Moysidou, Eleni
    Papagianni, Aikaterini
    Stangou, Maria
    LIFE-BASEL, 2022, 12 (10):
  • [20] Post-transplantation dynamics of non-HLA antibodies and early panel intensity as predictors of ABMR in kidney transplantation
    Tan, Jinghong
    Huang, Mingchuan
    Wu, Wenrui
    Zhang, Huanxi
    Liu, Longshan
    Wang, Changxi
    TRANSPLANTATION, 2024, 108 (09) : 337 - 337